SC
MDGL icon

Steven Cohen’s Madrigal Pharmaceuticals MDGL Stock Holding History

Steven Cohen’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
2,200
-2,300
-51% -$1.18M ﹤0.01% 2728
2026
Q1 		$2.36M Sell
4,500
-500
-10% -$239K ﹤0.01% 2198
2025
Q4 		$2.91M Buy
+5,000
New +$2.55M ﹤0.01% 2241
2024
Q2 		– Sell
-150,000
Closed -$40.1M – 2214
2024
Q1 		$40.1M Buy
+150,000
New +$35.3M 0.1% 251

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steven Cohen's MDGL Position: Q2 2026 in Review

Steven Cohen reduced its Madrigal Pharmaceuticals (MDGL) stake by 39% in Q2 2026, selling an estimated $45.3M and leaving 137,029 shares worth $73.6M. The position accounts for 0.08% of the portfolio, ranked #292.

Steven Cohen first reported a position in MDGL in Q4 2017 and has held it in 20 quarters since. The position peaked at $118M in Q1 2026. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Steven Cohen held 137,029 shares of Madrigal Pharmaceuticals worth $73.6M as of Q2 2026.
  • Steven Cohen sold 88,481 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $45.3M.
  • Madrigal Pharmaceuticals made up 0.08% of Steven Cohen's portfolio in Q2 2026, its #292 holding.
  • Steven Cohen first reported a position in Madrigal Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • Steven Cohen's Madrigal Pharmaceuticals position peaked at $118M in Q1 2026.
  • 411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.